Literature DB >> 27797903

Fractures in Patients with CKD: Time for Action.

Sharon M Moe1,2, Thomas L Nickolas3.   

Abstract

Entities:  

Keywords:  CKD; bone quality; chronic kidney disease; fracture; renal osteodystrophy

Mesh：

Year:  2016        PMID： 27797903      PMCID： PMC5108207          DOI： 10.2215/CJN.09500916

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  24 in total

Review 1.  NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7-29, 2000: highlights of the conference.

Authors: 
Journal:  South Med J       Date:  2001-06       Impact factor: 0.954

2.  Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone.

Authors:  M Coco; H Rush
Journal:  Am J Kidney Dis       Date:  2000-12       Impact factor: 8.860

3.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

4.  Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.

Authors:  Didier Hans; Andrew L Goertzen; Marc-Antoine Krieg; William D Leslie
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

5.  The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease.

Authors:  S A Jamal; S L West; T L Nickolas
Journal:  Osteoporos Int       Date:  2013-10-11       Impact factor: 4.507

6.  FRAX predicts fracture risk in kidney transplant recipients.

Authors:  Kyla L Naylor; William D Leslie; Anthony B Hodsman; David N Rush; Amit X Garg
Journal:  Transplantation       Date:  2014-05-15       Impact factor: 4.939

7.  Increased risk of hip fracture among Japanese hemodialysis patients.

Authors:  Minako Wakasugi; Junichiro James Kazama; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Ichiei Narita
Journal:  J Bone Miner Metab       Date:  2013-01-06       Impact factor: 2.626

8.  Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients.

Authors:  Anne C Beaubrun; Ryan D Kilpatrick; Janet K Freburger; Brian D Bradbury; Lily Wang; M Alan Brookhart
Journal:  J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 10.121

9.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

10.  A single-dose study of denosumab in patients with various degrees of renal impairment.

Authors:  Geoffrey A Block; Henry G Bone; Liang Fang; Edward Lee; Desmond Padhi
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741
View more
  18 in total

1.  Loss of bone mineral density and trabecular bone score in elderly hemodialysis patients: a 2-year follow-up, prospective, single-centre study.

Authors:  Ludmila Brunerová; Petr Kasalický; Jana Verešová; Renata Lažanská; Jana Potočková; Ivan Rychlík
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

Review 2.  The Non-invasive Diagnosis of Bone Disorders in CKD.

Authors:  Jordi Bover; Pablo Ureña-Torres; Mario Cozzolino; Minerva Rodríguez-García; Carlos Gómez-Alonso
Journal:  Calcif Tissue Int       Date:  2021-01-04       Impact factor: 4.333

3.  Predictors of bone fractures in a single-centre cohort of hemodialysis patients: a 2-year follow-up study.

Authors:  Ludmila Brunerová; Renata Lažanská; Petr Kasalický; Jana Verešová; Jana Potočková; Alena Fialová; Ivan Rychlík
Journal:  Int Urol Nephrol       Date:  2018-08-16       Impact factor: 2.370

4.  Calcimimetics Alter Periosteal and Perilacunar Bone Matrix Composition and Material Properties in Early Chronic Kidney Disease.

Authors:  John G Damrath; Sharon M Moe; Joseph M Wallace
Journal:  J Bone Miner Res       Date:  2022-06-03       Impact factor: 6.390

5.  Moderating Effect of the Lean Tissue Index on the Relationship between the Trabecular Bone Score and Augmentation Index in Dialysis Naïve Patients with Stage 5 Chronic Kidney Disease.

Authors:  Byoung-Geun Han; Daewoo Pak; Jun Young Lee; Jae-Seok Kim; Jae-Won Yang; Ki-Youn Kwon
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

Review 6.  Dietary Protein Intake and Bone Across Stages of Chronic Kidney Disease.

Authors:  Elizabeth R Stremke; Annabel Biruete; Kathleen M Hill Gallant
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

Review 7.  Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.

Authors:  P Evenepoel; J Cunningham; S Ferrari; M Haarhaus; M K Javaid; M-H Lafage-Proust; D Prieto-Alhambra; P U Torres; J Cannata-Andia
Journal:  Osteoporos Int       Date:  2021-06-15       Impact factor: 4.507

8.  Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.

Authors:  Neal X Chen; Shruthi Srinivasan; Kalisha O'Neill; Thomas L Nickolas; Joseph M Wallace; Matthew R Allen; Corinne E Metzger; Amy Creecy; Keith G Avin; Sharon M Moe
Journal:  J Bone Miner Res       Date:  2019-12-30       Impact factor: 6.390

Review 9.  The impact of advanced glycation end products on bone properties in chronic kidney disease.

Authors:  John G Damrath; Amy Creecy; Joseph M Wallace; Sharon M Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2021-07-01       Impact factor: 3.416

10.  Voluntary Wheel Running Has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD).

Authors:  Keith G Avin; Matthew R Allen; Neal X Chen; Shruthi Srinivasan; Kalisha D O'Neill; Ashley D Troutman; Garrison Mast; Elizabeth A Swallow; Mary Beth Brown; Joseph M Wallace; Teresa A Zimmers; Stuart J Warden; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2019-09-09       Impact factor: 14.978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.